Skip to content

The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an

The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an: A 10-Year Retrospective Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06952036
Enrollment
200000
Registered
2025-04-30
Start date
2025-04-25
Completion date
2025-12-31
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCV Elimination, HCV Infection

Keywords

Hepatitis C, HCV elimination, Women of childbearing age

Brief summary

The objectives of this study are to improve HCV linkage-to-care in Chinese women and provide theoretical basis for the scientific formulation of HCV prevention and control strategies for pregnant women. To understand the epidemiological changes and status of hepatitis C virus (HCV) infection in pregnant women in Shaanxi province in recent 10 years, and to analyze the main influencing factors of hepatitis C infection in pregnant women.

Interventions

PROCEDUREStandard Direct-acting antivirals (DAA) treatment procedures for patients with hepatitis C

Initiated Standard DAA treatment among HCV RNA positive patients.

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Pregnant women or parturient women confirmed by blood HCG test. 2. Patients aged 18 years old and above. 3. Patients with HCV antibody seropositive or HCV RNA positive from 2014-2023.

Exclusion criteria

1. Patients without valid telephone numbers. 2. Duplicate records: For duplicate records of the same pregnant woman, only one record should be kept.

Design outcomes

Primary

MeasureTime frameDescription
Relink rateFrom enrollment to the end of treatment at 12 weeksThe percentage of patients receiving DAA treatment among the diagnosed but untreated patients.

Contacts

Primary ContactYingli He
heyingli2000@xjtu.edu.cn+86-18991232863

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026